CNOT2

CCR4-NOT transcription complex subunit 2, the group of CCR4-NOT transcription complex

Basic information

Region (hg38): 12:70243002-70354993

Previous symbols: [ "NOT2" ]

Links

ENSG00000111596NCBI:4848OMIM:604909HGNC:7878Uniprot:Q9NZN8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies (Strong), mode of inheritance: AD
  • intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomaliesADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic31145527; 31512373

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CNOT2 gene.

  • not provided (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNOT2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
28
clinvar
3
clinvar
31
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
1
clinvar
1
clinvar
2
Total 2 1 30 4 0

Variants in CNOT2

This is a list of pathogenic ClinVar variants found in the CNOT2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-70278218-C-T not specified Uncertain significance (May 24, 2022)1696316
12-70278266-A-C CNOT2-related disorder Uncertain significance (Jun 26, 2023)2636366
12-70278281-C-T Likely benign (Dec 01, 2023)3025021
12-70286083-AGGAAATCTCAGTAAATAAGCGATCATATTTTCAAACACTATGTGAAAATAACAGAAGAGAGAACTTTATGACGTTAGAGAAGTTTATCTGAACAAAGCAGTATTCTAAAACTTCAGGAAGATTACATTCCTAAGAGGTCTTCTAGGAATGTATTTGGGAGTGTTTATACCAATTTTGAGCCCCATCAGTAGTCCTCATATTCATCTGACATTTGATAATTTCAGAATTAAAATTTTTTTCCATCTATTGAGGTTGTGTTTGAGATATATTGAGATATTCTTCATAGTCTTTTAAAAAAGATTTTTTGTTTTGTCTTCCATATTTAATCTACCTGAAATTGATTTTTGTACATGGTGTTAGAAGTACAGTTTCCTTTCCCCTGCACCTAAATTATCATATTAGCATTGTGTACCAATTTATTCTAACCTCCTTAACTATTCAGTAGTGCTAGCTCTATTGTAAATCAAGTTTCTCTTTATATGCATGGATTTCTTATGTCTCTGTTACCTTGATGTGTTTGTCTGTGCCTATACCAATATCATGTTTTCTTAAATACTAAAGCTTTGTGTTAAATCTTCATGTCTGTCTGTCAACCTTTTTCTTCATAAGAGTCTTGACTTGGCCTTTTGCTCTGTGACAAATTTAGAATATTCATGAGAATGCTCCCCTCCAACACAAAAAGAAGTATTGAGTTTGTAAGTGGAATTGCATTGACTTTAGTTTTCTTTGTGGAAGAATCGATAAGTTTATGTATTCTTTCATGTTTTCTCTCAAAGTTTTATATTTTTTTCATAAGGGACTTAGAAATCTTTAGTCCAATTTATGACTACTTTTGTTGCTTTTCTTGGTTGTAAATTAAAAAAAAATTTTTAGTTATAGGTGTTATTGAAATATAGTTGACTTTTAAAATTGATTTTTGTATCTCAATGTTGCTAAACTTTTTAATTTTTATAATTTATCTGTAGGCTTTTTGGGGGGTTCATATAAGTAAACACATCCTTTGGAAATGACAGTTTTGAAATTGTCACCAGTTTTGAAGTTGTCATCATTAAATAATATTTGATACAGGATTTTTTTTATAGATATACTTTATCAGGGTAAAGAAATTGTTCATAATGCTACCTTATATATTTTTTTCCTCTGTAGCATCTTTTTCTTCTTAAGGTTGTTTACTATGTGCGTTTTCCCCTTATTTGGTCAGACTTACTAGTGATTCGTCAGTTTTACTAGGGGTCAAATTTTAGCCTTTATTTATTTCTAAAATTTAATTTTGTTTTCTATTCATCAGTGTTCTTTAATGTTTTCCTTTCACTTCTTAGGGTTTGTTATACTGTTCTTTAATCTTACGTTTTTAATTTTCCAGGTAATTATCAGGTTTGTCTAGTTATCTTTTTGTTGCTGATTTCTCATATAATTCCATTTTGGTTCAAGAATGTGGTCTGTATGATACAATTATTTGTTTATGTGTTTGAACAAAATGTATATTAACCAAATTGGCAGGTGTATTGCTTTGTTTCTCTCCATTAGATCAAGTGTTAATCTTATTATGTACATCTTATGTATCCATATAATCATTTATCCCTTTGTTTAGATCTAGATTCCAATATATCTTATTTCTTTAATTATTTTATAAATTTTTGTGTTTAGCCTGTGATAAATCCAACAATTGGAAGTTGTCACATATTATGCTAATGTTTTTGTTTCTGCTGGTTCTCATTGTGCCTTGTTTCCTTGTGTGTATATTAAGCTATCATTTCATGTTTCTTAGAACTCTGGGAATTCTTTGAGCACTGGGTAGAAGGGGACATTTCTCCCAAGGGGATTTTCACTTGTTTTTGCTAAGACCCTAAGGCACTACCAATCCAGAACCAATTCCAAATAAAATATTAGCTTGAGGTTGCAGTCCACATAGGCAATGTGAATTTATGCTTTTTTGTGGCTATAAATTTTC-A Normal pregnancy not provided (-)157256
12-70286612-TATACCAATATCATGTTTTCTTAAATACTAAAGCTTTGTGTTAAATCTTCATGTCTGTCTGTCAACCTTTTTCTTCATAAGAGTCTTGACTTGGCCTTTTGCTCTGTGACAAATTTAGAATATTCATGAGAATGCTCCCCTCCAACACAAAAAGAAGTATTGAGTTTGTAAGTGGAATTGCATTGACTTTAGTTTTCTTTGTGGAAGAATCGATAAGTTTATGTATTCTTTCATGTTTTCTCTCAAAGTTTTATATTTTTTTCATAAGGGACTTAGAAATCTTTAGTCCAATTTATGACTACTTTTGTTGCTTTTCTTGGTTGTAAATTAAAAAAAAATTTTTAGTTATAGGTGTTATTGAAATATAGTTGACTTTTAAAATTGATTTTTGTATCTCAATGTTGCTAAACTTTTTAATTTTTATAATTTATCTGTAGGCTTTTTGGGGGGTTCATATAAGTAAACACATCCTTTGGAAATGACAGTTTTGAAATTGTCACCAGTTTTGAAGTTGTCATCATTAAATAATATTTGATACAGGATTTTTTTTATAGATATACTTTATCAGGGTAAAGAAATTGTTCATAATGCTACCTTATATATTTTTTTCCTCTGTAGCATCTTTTTCTTCTTAAGGTTGTTTACTATGTGCGTTTTCCCCTTATTTGGTCAGACTTACTAGTGATTCGTCAGTTTTACTAGGGGTCAAATTTTAGCCTTTATTTATTTCTAAAATTTAATTTTGTTTTCTATTCATCAGTGTTCTTTAATGTTTTCCTTTCACTTCTTAGGGTTTGTTATACTGTTCTTTAATCTTACGTTTTTAATTTTCCAGGTAATTATCAGGTTTGTCTAGTTATCTTTTTGTTGCTGATTTCTCATATAATTCCATTTTGGTTCAAGAATGTGGTCTGTATGATACAATTATTTGTTTATGTGTTTGAACAAAATGTATATTAACCAAATTGGCAGGTGTATTGCTTTGTTTCTCTCCATTAGATCAAGTGTTAATCTTATTATGTACATCTTATGTATCCATATAATCATTTATCCCTTTGTTTAGATCTAGATTCCAATATATCTTATTTCTTTAATTATTTTATAAATTTTTGTGTTTAGCCTGTGATAAATCCAACAATTGGAAGTTGTCACATATTATGCTAATGTTTTTGTTTCTGCTGGTTCTCATTGTGCCTTGTTTCCTTGTGTGTATATTAAGCTATCATTTCATGTTTCTTAGAACTCTGGGAATTCTTTGAGCACTGGGTAGAAGGGGACATTTCTCCCAAGGGGATTTTCACTTGTTTTTGCTAAGACCCTAAGGCACTACCAATCCAGAACCAATTCCAAATAAAATATTAGCTTGAGGTTGCAGTCCACATAGGCAATGTGAATTTATGCTTTTTTGTGGCTATAAATTTTC-T Normal pregnancy not provided (-)157257
12-70310893-A-C Uncertain significance (Feb 29, 2024)3373462
12-70310941-G-A Inborn genetic diseases Likely benign (Sep 01, 2023)1298550
12-70310991-A-G Inborn genetic diseases Likely benign (Jan 01, 2024)2672511
12-70311004-G-A Inborn genetic diseases Uncertain significance (Jan 30, 2024)3146605
12-70319329-TGTCTCAGT-ACCATCTACA Pathogenic (Feb 15, 2024)3369381
12-70329437-C-G Inborn genetic diseases Uncertain significance (Dec 07, 2023)3146606
12-70329453-G-A CNOT2-related disorder Uncertain significance (Apr 17, 2024)3357651
12-70329469-G-A CNOT2-related disorder Likely benign (Jan 14, 2024)3058220
12-70329477-G-A Uncertain significance (Jul 23, 2024)3600889
12-70329504-C-T Inborn genetic diseases Uncertain significance (Nov 08, 2022)2209448
12-70329512-G-A Inborn genetic diseases Uncertain significance (Mar 16, 2024)3268205
12-70329519-C-T Uncertain significance (May 09, 2023)2662035
12-70330306-C-T Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies Uncertain significance (Nov 15, 2021)2440168
12-70330346-T-C Inborn genetic diseases Uncertain significance (May 30, 2024)3268208
12-70330448-G-A Inborn genetic diseases Uncertain significance (Jun 02, 2023)2510432
12-70332780-G-A Uncertain significance (May 31, 2023)3343663
12-70335471-C-A Inborn genetic diseases Pathogenic (May 11, 2022)3146607
12-70335494-C-G Inborn genetic diseases Uncertain significance (Nov 10, 2024)3494479
12-70335498-A-G Inborn genetic diseases Likely benign (Apr 07, 2022)1049790
12-70335499-C-G Inborn genetic diseases Uncertain significance (May 09, 2024)3268207

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CNOT2protein_codingprotein_codingENST00000229195 15112000
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000187124567021245690.00000803
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.651192950.4030.00001483566
Missense in Polyphen1777.7540.21864986
Synonymous0.942921040.8830.00000546999
Loss of Function5.03233.30.06000.00000181384

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001770.0000177
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA-mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Required for the CCR4-NOT complex structural integrity. Can repress transcription and may link the CCR4-NOT complex to transcriptional regulation; the repressive function may specifically involve the N-Cor repressor complex containing HDAC3, NCOR1 and NCOR2. Involved in the maintenance of emryonic stem (ES) cell identity. {ECO:0000269|PubMed:14707134, ECO:0000269|PubMed:16712523, ECO:0000269|PubMed:21299754, ECO:0000269|PubMed:22367759}.;
Pathway
RNA degradation - Homo sapiens (human);Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Metabolism of RNA;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;TP53 Regulates Transcription of Cell Cycle Genes;Transcriptional Regulation by TP53;Deadenylation of mRNA;Deadenylation-dependent mRNA decay (Consensus)

Recessive Scores

pRec
0.142

Intolerance Scores

loftool
rvis_EVS
-0.12
rvis_percentile_EVS
44.89

Haploinsufficiency Scores

pHI
0.287
hipred
Y
hipred_score
0.739
ghis
0.616

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.988

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cnot2
Phenotype

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;nuclear-transcribed mRNA poly(A) tail shortening;trophectodermal cell differentiation;regulation of transcription by RNA polymerase II;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;positive regulation of cytoplasmic mRNA processing body assembly;negative regulation of translation;gene silencing by RNA;negative regulation of intracellular estrogen receptor signaling pathway;RNA phosphodiester bond hydrolysis, exonucleolytic;regulation of stem cell population maintenance
Cellular component
P-body;nucleus;cytoplasm;cytosol;plasma membrane;membrane;CCR4-NOT complex;CCR4-NOT core complex
Molecular function
RNA polymerase II transcription corepressor binding;transcription coregulator activity;poly(A)-specific ribonuclease activity;protein binding